This news is delayed by 15 minutes, sign up now to get live news & full features.
INZY INOZYME PHARMA INC
+ add to watchlist
$4.79
we are a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases. our area of expertise is in disorders of paradoxical mineralization and our lead drug is an enzyme replacement therapy in pre-clinical development.
Mkt Cap: $257.28M
52 Week High: $4.00
P/E: 0.00
52 Week Low: $0.72
Dividend: $0.00
Shares Outstanding: 64.56M